When compliance is an issue-how to enhance statin adherence and address adverse effects

Area of Science:

• Cardiology
• Pharmacology
• Health Services Research

Background:

• Cardiovascular disease (CVD) presents a significant public health challenge, characterized by high prevalence and substantial economic burden.
• Statins are primary interventions for reducing CVD morbidity and mortality, yet suboptimal patient adherence limits their effectiveness.
• Factors influencing statin adherence require thorough understanding for optimizing patient outcomes.

Purpose of the Study:

• To identify key patient- and insurance plan-specific factors affecting statin adherence.
• To explore the impact of perceived statin-related side effects, particularly myalgia, on treatment adherence.
• To emphasize the importance of clinician-patient collaboration in managing statin therapy and side effects.

Main Methods:

• Review of existing literature on statin adherence and influencing factors.
• Analysis of patient-reported outcomes and insurance data related to statin use.
• Clinical assessment of myalgia and its differential diagnosis in patients on statin therapy.

Main Results:

• Suboptimal adherence to statin therapy is a widespread issue impacting CVD outcomes.
• Patient-specific factors and insurance plan characteristics significantly influence adherence rates.
• Statin-related myalgia is a common concern that can lead to unnecessary discontinuation of beneficial therapy.

Conclusions:

• Optimizing statin adherence requires a multifaceted approach addressing patient, provider, and systemic factors.
• Effective management of statin-related side effects, especially myalgia, is critical to prevent premature treatment cessation.
• Enhanced clinician-patient communication and shared decision-making are essential for improving long-term statin adherence and CVD prevention.